Researchers Develop BioTAK Score to Identify Broken Heart Syndrome

Researchers have developed and validated the BioTAK score, a novel diagnostic tool combining biological sex and four blood biomarkers to accurately identify takotsubo syndrome—commonly known as broken heart syndrome—before patients undergo invasive cardiac catheterization.

Diagnosing takotsubo syndrome has long presented a frustrating clinical puzzle for emergency physicians. The condition mimics a classic heart attack by causing sudden chest pain, abnormal electrocardiogram readings, and elevated cardiac enzymes. Yet it develops through entirely different mechanisms than a traditional myocardial infarction, which is triggered by a ruptured plaque blocking a coronary artery. Instead, takotsubo involves a surge of stress hormones and disrupted signaling between the brain and the heart, leaving the coronary arteries completely clear of obstruction. Traditionally, distinguishing the two conditions required an invasive procedure involving a catheter threaded through blood vessels to the heart.

How the BioTAK Diagnostic Score Operates

By examining blood samples and clinical profiles from more than 3,600 patients across multiple cohorts, the research team used artificial intelligence to pinpoint five key factors that distinguish stress cardiomyopathy from a traditional heart attack.

PAM (peptidylglycine alpha-amidating monooxygenase), a marker linked to blood vessel tightening and anxiety response.

Validation results demonstrate high reliability. When tested on an independent validation group of 1,792 patients, the BioTAK score correctly classified nearly 90 percent of participants before they underwent cardiac catheterization.

“Our study shows that a simple combination of blood biomarkers and biological sex can identify these patients with remarkable accuracy even before cardiac catheterization.”

Florian A. Wenzl, Center for Molecular Cardiology at the University of Zurich and Radcliffe Department of Medicine at the University of Oxford, via ScienceDaily

Unlocking the Brain-Heart Connection

Beyond its immediate utility in emergency triage, the BioTAK score sheds light on the underlying biology of takotsubo syndrome. The inclusion of biomarkers like PAM highlights the active role of the brain-heart axis. PAM helps activate neuropeptides that govern stress responses, anxiety, vascular tone, and autonomic nervous system activity.

Researchers Develop BioTAK Score to Identify Broken Heart Syndrome — Photo: Nautilus | Science

Co-investigators note that these biological pathways allow the tool to translate complex disease mechanisms into practical clinical insights. Researchers emphasize that while the score is not meant to replace catheterization when it is medically necessary, it could streamline diagnostic procedures and spare selected patients from unnecessary invasive tests.

Demographics, Mortality Risks, and Imaging Challenges

Epidemiological data underscore stark demographic divides in how takotsubo syndrome manifests and impacts patients. The condition overwhelmingly affects postmenopausal women, who account for around 80 percent of all documented cases. Case studies published in the European Heart Journal Case Reports reveal that severe fluid retention and myocardial swelling during the subacute phase of takotsubo can temporarily simulate apical hypertrophic cardiomyopathy, emphasizing the ongoing need for advanced tissue mapping and serial cardiac evaluations to secure an accurate diagnosis.

Implementation Hurdles and Future Outlook

Despite the strong performance metrics demonstrated in retrospective cohorts, several practical hurdles remain before the BioTAK score can become a universal fixture in emergency departments. Two of the five required biomarkers are not yet standard components of routine hospital laboratory panels. Furthermore, clinical trials have not yet evaluated whether integrating the tool into daily practice directly improves long-term patient outcomes.

Future investigations will focus on prospective clinical trials to see how the blood-based score performs under real-world emergency conditions. Until those results are clear, the medical community continues to refine how it separates acute stress responses from traditional coronary events, aiming to balance diagnostic speed against procedural safety.